Altered levels of APP and its metabolites are found in Fmr1KO mice, a mouse model that lacks expression of FMRP, as well as in subjects with autism and FXS (Westmark and Malter, 2007; Ray et al., 2011, 2016; Westmark et al., 2011). Here, APP is linked to fragile X syndrome.